Chloride channel (ClC) is involved in normal physiological processes and pathology of various diseases. although it is recognized that blockade of ClC inhibits the cell proliferation, it is not well understood the potential function of ClC in laryngeal cancer. In this study, we investigated the effect of the ClC inhibitor on cell proliferation, cell cycle progression in human laryngeal cancer cell line Hep-2, as well as the effect on the phosphorylation levels of eRK1/2 and aKT1. In this study crystal violet method was used to study the effect of the ClC inhibitor, 5-nitro-2-(3-phenylpropylamino) benzoic acid, NppB, on Hep-2 cell proliferation. The impaction of the inhibitor on the cell cycle distribution was investigated by the flow cytometry (FCm). Western blot was performed to measure the phosphorylation levels of eRK1/2 and aKT1. our data indicated ClC played an important role in Hep-2 cell proliferation and cell cycle. NppB inhibited Hep-2 cell proliferation when compared with the controls. Blockade of ClC arrested cell cycle progression and suppressed the phosphorylation of eRK1/2 and aKT1 in Hep-2 cells by inhibition of cell proliferation by CIC inhibitor (NppB) could be through arresting cell cycle progression, which is probably by suppressing phosphorylation of eRK1/2 and aKT1.
It is well known that head and neck cancer is the eighth most common cause of cancer death worldwide [1] . la ryn geal cancer is one of the head and neck malignant tu mors that se riously lead to health damage. It is very common in Brazil, Hong Kong, Italy and among the Black populations in parts of Usa. There are also areas of low incidence in Japan, Nor way, swe den and senegal. In each country there exist difference in in ci dence among urban and rural areas, the former having higher incidence [2] . pathogenesis of la ryn geal cancer is still not clear. It is be coming clear that cell ion transport proteins function as part of larger mac ro mo lecu lar complexes [3] [4] [5] [6] is nec essary for the cell bio syn the sis, signal transduction, and function of membrane nor mal re ceptors [7] [8] [9] . Recently, some reports showed that cell ClC play a critical role in cell proliferation and differentiation. For ex ample, in most cell types studied, cell swelling results in activation of ClC [10] [11] [12] [13] [14] , and, particularly in mamma lian cells. ClC is char ac terized as an outwardly rec ti fying current that is in hib ited by a variety of nonspecific ClC in hibitors including both 5-nitro-2 (3-phenylpropylamino) ben zoic acid (NppB) and DIDs [12, 14, 15, 16] , and is thought to be one of the ma jor osmolytes involved in cancer cells. Vol ume-regulated chlo ride currents have been in volved in the con trol of the cell cycle [17] [18] [19] . Therefore, un der standing the mecha nisms and func tional sig nifi cance of ClC is essential for the therapy of la ryn geal can cer. However, the functions of ClC in laryngeal tumor cells still remains unknown. In the present study we investigated the effect of NppB on cell pro lif eration and cell cycle in Hep-2 cells.
It is known that signal transduction pathways play im por tant role in cellular proliferation and differentiation. They are often orchestrated by mitogen-activated protein kinases (mapKs) [20] . mapK is proline-directed serine/threonine ki nase that have been classified into at least six subfamilies, of which eRK1/2, JNK1/2, and p38 are the most extensively stud ied [21] . eRK1/2 is nor mally activated by growth signals and mainly associated with cell cycle arrest, apoptosis and tumor formation [22, 23] . an other important kinase is akt/protein kinase B. It is a central regulator of cell survival [24, 25] and akt activation is required for many types of human tumors [26, 27] . INHIBITION OF CELL PROLIFERATION BY BLOCKING CHANNELS Therefore, the purpose of this study is to determine the role of ClC in laryngeal cancer. We examined the effects of NPPB on the cell proliferation and cell cycle in Hep-2 cells, and the signaling pathway involving ERK1/2 and Akt1.
Materials and methods
Cell culture. Human laryngeal cancer Hep-2 cells were purchased from the Cell Resource Center of Shanghai Academy of Life Science of Chinese Academy of Science. Cells were grown in RPMI-1640 with 5%(v/v) decomplemented fetal bovine serum (FBS) (Gibco Life Technologies, Grand Island, NY, USA), at 37°C in a humidified atmosphere containing 5% (v/v) CO 2 . The medium was supplemented with 300 μg/ml L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were seeded in 75 cm 2 flasks, and the growth medium was renewed every second day. For the experiments, the cells were subcultured in 35 mm petri dishes (Nunc) and used after 3-5 days.
Cell Proliferation. Cell proliferation was assayed as described [28, 29] . Hep-2 cells were cultured in 96-well plates (4000-6000 cells/well) for 24h, starvation for overnight. Added 5%(v/v) decomplemented fetal bovine serum, cells were treated without(control) or with NPPB at 50, 100, 150, and 200μM(6 wells/dose). After another 48 hr of culture, the number of cells was determined. Briefly, wells were rinsed with PBS, fixed in methanol, air-dried, and stained with 0.1% (w/v) crystal violet. Wells were rinsed with distilled water, and air-dried again. Once dried, cells were lysed with 2% (w/ v) sodium deoxycholate solution with gentle agitation. Absorbance was measured at 570 nm on a microplate reader (Bio Tek Instrument, Winooski, VT). Wells containing known cell numbers (0, 1000, 2000, 5000, 10000, 20000 or 40000 cells/ well; 6 wells/cell density) were treated in the similar fashion to establish standard curves. Cell proliferation studies were run in five independent experiments.
Cell viability.The cell viability was detected by trypan blue rejection. After Hep-2 cells stained by trypan blue, the number of Hep-2 cells unstained by trypan blue was accounted by microscope, and then we computed cellular survival rate.
Cell cycle progression. Hep-2 cells were inoculated into culture bottles when the cells in the mid-log phase of growth. They were divided into four groups, including of control group; 50μM-NPPB group, 100μM-NPPB group and 150μM-NPPB group. There were three repeated bottles for each group. The cells were then cultured in RPMI-1640 alone or in RPMI-1640 with the corresponding NPPB concentration when the cells were in the denary logarithmic growth condition. Cells were collected from each bottle after 24 hrs and 48 hrs. A unicellular suspension was prepared and the cell concentration was adjusted to 1×10 6 /ml, the agent was then added according to the kit instructions. The cell cycle of each treatment group was measured using FCM to determine.
Western blotting analysis. Western blot analysis was performed as described [28, 29] . After 16 hours of serum-deprivation, cells were treated with 50, 100 and 150μM of NPPB (Pepro Tech, Rocky Hill, NJ) for 0-8 hours. To determine changes in total and phosphorylated ERK1/2 and AKT1 protein levels, cells were washed twice with cold PBS, harvested and then lysed by sonication in buffer (4 mM sodium pyrophosphate; 50 mM HEPES, pH 7.5; 100 mM NaCl; 10 mM EDTA; 10 mM sodium fluoride; 2 mM sodium orthovanadate [Na3VO4]; 1 mM PMSF; 1% Triton X-100; 5 mg/ml leupeptin; and 5 mg/ml of aprotinin). The protein concentrations in supernatants of the lysates were determined. Proteins (15-20 μg/lane) were subjected to Western blot analysis. Proteins were separated on 10% SDS-PAGE gels and electroblotted onto Immobilon-P membrane (Millipore, Bedford, MA), Proteins on the membranes were probed with an antibody against total or phospho-specific ERK1/2 (1:2000; Cell Signaling Technology, Beverly, MA), total (1:2000; Cell Signaling Technology) or phospho-specific AKT1 (1:1000; Cell Signaling Technology). The membranes were reprobed for GAPDH as described above. Changes in total and phosphorylated ERK1/ 2and AKT1 protein levels were quantified. Data on phosphorylated ERK1/2 and AKT1 were normalized to total ERK1/2 and AKT1. Data on total ERK1/2 and AKT1 were normalized to GAPDH. The kinase studies were run in at least three independent experiments.
Statistical analysis. The data were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett's posthoc analysis. Statistical significance was defined as p < 0.05. SPSS 13.0 for Windows was used for all the analyses. proliferation in a dose-dependent manner (Figure 1 ). NPPB at the concentration of 50μM, 100μM and 150μM inhibited Hep-2 cell proliferation, but did not significantly alter cell viability. As compared with the control group, the cellular survival rate was not changed significantly (p > 0.05) .84) the cell ratio of S-phase and G2/M-phase decreased (p < 0.05) (t[1]=3.05) correspondingly after various levels of NPPB were added for 24 hours. After 48 hours, the cell ratio of G0/G1 phase reached a peak then decreased especially in the 150μM-NPPB group (Table 1) 
Results

Blockade of ClC significantly inhibited
Discussion
Blockade of ClC inhibited Hep-2 cells proliferation and increased cell cycle arrest.
ClC has been referred to as "the problem of chloride ion channels" [30] , and the field harbors considerable controversies. The role of ClC in human laryngeal cancer is poorly defined. In this study, for the first time in human laryngeal cancer Hep-2 cells, we have demonstrated successfully that blockade of ClC with NPPB dose-dependently significantly inhibited Hep-2 cell proliferation. These data implicate a direct link between ClC and Hep-2 cell proliferation. This conclusion is in agreement with the previously published data. For example, it has been demonstrated that cell division could be inhibited by channel blockers [31] [32] [33] . Similarly, the proliferation of C6 glioma cells, rat aortic smooth muscle cells, and mouse liver cells is inhibited after ClC knockdown [34] [35] [36] . The reduction in cell proliferation observed in this study may be mediated by a number of factors. It is well known that cell cycle analysis was carried out to elucidate the antiproliferative activity. Increasing cell cycle arrest in the G0/G1 phase of the cell cycle may mediate its antiproliferative effects via its impact on cell cycle progression. These results are similar to data obtained using the human cervical epithelial cell-lines SiHa and HeLa [37, 38] . In both studies, NPPB increased the cells arrested in G0/G1. On the other hand, increased chloride channels activity has been shown to coincide with the entry into the cell cycle of human cervical cancer cells [39] .
What is the mechanism of NPPB dose-dependently inhibited-cell proliferation with arrested cell cycle progression? Did NPPB kill Hep-2 cells directly? To answer these questions, Hep-2 cells viability was determined.Blockade of CIC with NPPB (50, 100 and 150μM), the cell survival rates did not change remarkably. This indicated that inhibition of Hep-2 cells proliferation and arrest of cell cycle by blocking ClC has other reasons.
Blockade of ClC decreased the phosphorylation of ERK1/ 2 and AKT1 It is well known that ERK1/2 and AKT1 are actively involved in the regulation of cell function. Firstly, ERK1/2, a member of the MAP kinase family, is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. This pathway is constitutively active in several human malignancies and may be involved in the pathogenesis of these tumors [40] . The ERK1/ 2 pathway mediates ligand-stimulated signals for the induction of cell proliferation, differentiation, and cell survival [41, 42] . It has been shown that MAP kinases Erk1/2 was involved in the activation of volume-sensitive chloride channels in astrocytes [43] . In this study, we examined the phosphorylation of ERK1/2 before and after blockade of ClC. We have demonstrated successfully that NPPB (50, 100 and 150μM) inhibited the phosphorylation of ERK1/2 in Hep-2 cells. The reasons may be that the volume-sensitive chloride channel appears to be a cytoplasmic target for the MAP kinase signaling pathway [43] . When chloride channels were blocked by NPPB (50, 100 and 150μM), the MAP kinase signaling pathway was influenced. Therefore, the phosphorylation of ERK1/ 2 was inhibited. This conclusion agreed with those studies. For example, the MAP kinase kinase inhibitor PD 98059 reversibly inhibited activation of the chloride current by hypo-osmotic solution [43] .
Secondly, protein kinase B (PKB/Akt) is a pivotal regulator of diverse metabolic, phenotypic, and antiapoptotic cellular controls, and also well known to be involved in transformation and cell survival. It is a critical kinase that regulates events downstream of growth factor receptors. AKT has been shown to be a key player in cancer progression, where its overexpression induces malignant transformation. It affects prosurvival proteins as well. Blocking the flow-activated chloride current abolished flow-induced Akt phosphorylation in BAECs [44] . It was also reported that volume-sensitive chloride currents I (Cl,vol) inhibitors in preventing doxorubicin-induced apoptosis and subsequent contractile dysfunction through AKT in cardiomyocytes [45] . In the current study, we examined the phosphorylation of AKT1 before and after blockade of ClC. We have demonstrated successfully that NPPB(50, 100 and 150μM) inhibited the phosphorylation of AKT1.
As shown above, blockade of ClC inhibited both the Hep-2 cells proliferation and the phosphorylation of ERK1/2 and AKT1. We examined further the relationship between NPPB inhibited-cell proliferation and the phosphorylation of ERK1/2 and AKT1. The data indicated that the concentration dependence of NPPB inhibition of cell proliferation was in excellent agreement with the phosphorylation of ERK1/2 and AKT1. The inhibition of the cell proliferation by NPPB was positively related to phosphorylation of ERK1/2 and AKT1. These results are in agreement with those studies above.
Taken together, our current study has shown for the first time that blockade of ClC inhibited Hep-2 cell proliferation and arrested cell cycle progression by inhibiting ERK1/2 and AKT1 activation. Further experiments are required using different types of tumor cells. Future studies are needed to dissect the mechanism, which may provide fundamental information for ClC.
In conclusion, in Hep-2 cells ClC played an important role in cell proliferation and cell cycle. ClC inhibitor (NPPB) doesdependly inhibited cell proliferation and arrested cell cycle progression, which is probably by suppressing phosphorylation of ERK1/2 and AKT1. We thank Dr. Yang Yunlie from Mount Sinai School of Medicine for critically reading this manuscript.
